Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PP1131
- Development stage
- Phase 2
- Lead developer
- PHAXIAM Therapeutics
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Topical
01
Overview
**PP1131** is an investigational topical bacteriophage product developed by Pherecydes Pharma for *Pseudomonas aeruginosa* burn-wound infections. It is a defined cocktail of 12 natural lytic anti-*P. aeruginosa* bacteriophages intended to infect, replicate within, and lyse susceptible bacterial cells. In the randomized Phase 1/2 PhagoBurn trial, PP1131 was administered daily to burn wounds for 7 days, but the trial was stopped because the product delivered at a substantially lower-than-intended phage titre and reduced bacterial burden more slowly than silver sulfadiazine standard care. ([iris.unil.ch](https://iris.unil.ch/entities/publication/acdce1bd-7105-4afa-b3f5-36ff478e9a9c))
- Brand names
- Phagoburn
- Other names
- Phagoburn cocktailPherecydes phage cocktail
02
Targets
P. aeruginosa (Pseudomonas aeruginosa)
Beyond the preview
Go deeper on PP1131.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PP1131.